These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29226117)

  • 1. Pediatric Anti-
    Remy KE; Custer JW; Cappell J; Foster CB; Garber NA; Walker LK; Simon L; Bagdure D
    Front Pediatr; 2017; 5():250. PubMed ID: 29226117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents: A Systematic Review and Quantitative Analysis of Reported Cases.
    Giri YR; Parrill A; Damodar S; Fogel J; Ayed N; Syed M; Korie I; Ayyanar S; Typhair C; Hashmi S
    J Can Acad Child Adolesc Psychiatry; 2021 Nov; 30(4):236-248. PubMed ID: 34777507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 4. Early Functional Outcomes for Pediatric Patients Diagnosed with Anti-N-Methyl-D-Aspartate Receptor Encephalitis during Inpatient Rehabilitation.
    Howarth RA; Vova J; Blackwell LS
    Am J Phys Med Rehabil; 2019 Jul; 98(7):529-535. PubMed ID: 30379652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents.
    Scheer S; John RM
    J Pediatr Health Care; 2016; 30(4):347-58. PubMed ID: 26507948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.
    Kuppuswamy PS; Takala CR; Sola CL
    Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agitation Management in Pediatric Males with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Schumacher LT; Mann AP; MacKenzie JG
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):939-943. PubMed ID: 27992257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis.
    DeSena AD; Greenberg BM; Graves D
    Pediatr Neurol; 2014 Oct; 51(4):542-9. PubMed ID: 25070939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-NMDA-receptor antibody encephalitis in infants.
    Matoq AA; Rappoport AS; Yang Y; O'Babatunde J; Bakerywala R; Sheth RD
    Epilepsy Behav Case Rep; 2015; 4():99-101. PubMed ID: 26744696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-
    John CM; Mathew DE; Abdelaziz M; Mahmoud AAH; AlOtaibi AD; Sohal APS
    J Pediatr Neurosci; 2019; 14(4):180-185. PubMed ID: 31908658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric anti-NMDA (N-methyl D-aspartate) receptor encephalitis.
    Salvucci A; Devine IM; Hammond D; Sheth RD
    Pediatr Neurol; 2014 May; 50(5):507-10. PubMed ID: 24656207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
    Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
    Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
    Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Care Management of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Neyens RR; Gaskill GE; Chalela JA
    Crit Care Med; 2018 Sep; 46(9):1514-1521. PubMed ID: 29927776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.
    Armangue T; Titulaer MJ; Málaga I; Bataller L; Gabilondo I; Graus F; Dalmau J;
    J Pediatr; 2013 Apr; 162(4):850-856.e2. PubMed ID: 23164315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.
    DeSena AD; Noland DK; Matevosyan K; King K; Phillips L; Qureshi SS; Greenberg BM; Graves D
    J Clin Apher; 2015 Aug; 30(4):212-6. PubMed ID: 25664728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Cordani R; Micalizzi C; Giacomini T; Gastaldi M; Franciotta D; Fioredda F; Buratti S; Morana G; Pirlo D; Renna S; Castagnola E; Risso M; Lanteri P; Vari MS; Mancardi MM
    Pediatr Neurol; 2020 Feb; 103():61-64. PubMed ID: 31759783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of anti
    Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
    Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.
    Wright S; Hacohen Y; Jacobson L; Agrawal S; Gupta R; Philip S; Smith M; Lim M; Wassmer E; Vincent A
    Arch Dis Child; 2015 Jun; 100(6):521-6. PubMed ID: 25637141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.